These results suggest that KPNB1 inhibition-upregulated cell surface DR5 mainly amplifies the death receptor signaling transduction favoring TRAIL-triggered apoptosis in tested glioblastoma cells. This evidence concerns the gene TNFSF10 and glioblastoma.